These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 19476613)

  • 1. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine modification of inhibitory oligonucleotides potentiates their suppressive function.
    Römmler F; Jurk M; Uhlmann E; Hammel M; Waldhuber A; Pfeiffer L; Wagner H; Vollmer J; Miethke T
    J Immunol; 2013 Sep; 191(6):3240-53. PubMed ID: 23966630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
    Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
    Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
    Lenert PS
    Arthritis Res Ther; 2006; 8(1):203. PubMed ID: 16542467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Nanoflowers' Amelioration of Lupus Symptoms in Mice via Blockade of TLR7/9's Signal.
    Wang J; Gan M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
    Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
    Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
    Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
    J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
    Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
    J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.
    Sang A; Niu H; Cullen J; Choi SC; Zheng YY; Wang H; Shlomchik MJ; Morel L
    J Immunol; 2014 Aug; 193(4):1609-21. PubMed ID: 25015835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
    Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
    Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
    Yan J; Mamula MJ
    Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
    Brummel R; Lenert P
    J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
    Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
    Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
    Brummel R; Roberts TL; Stacey KJ; Lenert P
    Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
    Beaudette-Zlatanova BC; Ling T; Shlomchik MJ; Marshak-Rothstein A; Rifkin IR
    J Immunol; 2006 Jul; 177(1):45-52. PubMed ID: 16785497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
    Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
    Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.